World's Best Scientists 2026 revealed!
Mark A. Perazella

Mark A. Perazella

D-Index & Metrics

Medicine

D-Index
89
Citations
24386
World Ranking
12839
National Ranking
6566

Mark A. Perazella publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark A. Perazella sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 411 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Mark A. Perazella D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark A. Perazella sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Mark A. Perazella is affiliated with Yale University in the United States and specializes in the field of Medicine with a focus on Nephrology. Their research encompasses a range of subfields including Pulmonary and Respiratory Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, and Pharmacology.

The scientist's work addresses several main topics in medical research: Chronic Kidney Disease and Diabetes, Nephrotoxicity and Medicinal Plants, Renal Diseases and Glomerulopathies, Acute Kidney Injury Research, Cancer Immunotherapy and Biomarkers, Renal Cell Carcinoma Treatment, and Methemoglobinemia and Tumor Lysis Syndrome.

Mark A. Perazella has published extensively in prominent journals. Frequent publication venues include:

  • Kidney360 (18 publications)
  • Kidney International (5 publications)
  • Nephrology Dialysis Transplantation (5 publications)
  • Journal of the American Society of Nephrology (5 publications)
  • American Journal of Kidney Diseases (4 publications)

Some of the recent papers authored or co-authored by this researcher include:

  • Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference, 2020, Kidney International
  • Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation, 2020, Radiology
  • NSAIDs in CKD: Are They Safe?, 2020, American Journal of Kidney Diseases
  • Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation, 2020, Radiology
  • Onconephrology: The intersections between the kidney and cancer, 2020, CA A Cancer Journal for Clinicians

Collaborations form a significant part of their research output. Frequent co-authors include:

  • Dennis G. Moledina
  • Kenar D. Jhaveri
  • Chirag R. Parikh
  • F. Perry Wilson
  • Randy L. Luciano

Best Publications

  • Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

    Andrew S. Levey;Kai-Uwe Eckardt;Nijsje M. Dorman;Stacy L. Christiansen

  • The renin-angiotensin-aldosterone system and the kidney: effects on kidney disease.

    Ursula C Brewster;Mark A Perazella

  • Plasma neutrophil gelatinase-associated lipocalin is an early biomarker for acute kidney injury in an adult ICU population

    Dinna N. Cruz;Massimo de Cal;Francesco Garzotto;Mark A. Perazella

  • Effectiveness of polymyxin B-immobilized fiber column in sepsis: a systematic review

    Dinna N Cruz;Mark A Perazella;Rinaldo Bellomo;Massimo de Cal

  • Renal Vulnerability to Drug Toxicity

    Mark A. Perazella

  • Use of Intravenous Iodinated Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation.

    Matthew S. Davenport;Matthew S. Davenport;Mark A. Perazella;Mark A. Perazella;Jerry Yee;Jonathan R. Dillman;Jonathan R. Dillman

  • Drug-induced acute interstitial nephritis

    Mark A. Perazella;Glen S. Markowitz

  • Crystal-induced acute renal failure

    Mark A. Perazella

  • Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury

    Justin M. Belcher;Arun J. Sanyal;Aldo J. Peixoto;Mark A. Perazella

  • North East Italian Prospective Hospital Renal Outcome Survey on Acute Kidney Injury (NEiPHROS-AKI): Targeting the Problem with the RIFLE Criteria

    Dinna N. Cruz;Irene Bolgan;Mark A. Perazella;Monica Bonello

  • Nephrotoxicity From Chemotherapeutic Agents: Clinical Manifestations, Pathobiology, and Prevention/Therapy

    Mark A. Perazella;Gilbert W. Moeckel

  • Association of Acute Interstitial Nephritis With Programmed Cell Death 1 Inhibitor Therapy in Lung Cancer Patients

    Anushree C. Shirali;Mark A. Perazella;Scott Gettinger

  • Current Status of Gadolinium Toxicity in Patients with Kidney Disease

    Mark A. Perazella

  • The Renin-Angiotensin-Aldosterone System: Cardiorenal Effects and Implications for Renal and Cardiovascular Disease States

    Ursula C Brewster;John F Setaro;Mark A Perazella

  • Onco-Nephrology: Renal Toxicities of Chemotherapeutic Agents

    Mark A. Perazella

  • Adverse renal effects of anti‐inflammatory agents: evaluation of selective and nonselective cyclooxygenase inhibitors

    Giovanni Gambaro;M. a. Perazella

  • Drug-induced hyperkalemia: old culprits and new offenders

    Mark A Perazella

  • Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity.

    Mark A. Perazella

  • Acute Kidney Injury in Patients with Cancer

    Mitchell H. Rosner;Mark A. Perazella

  • Drug-Induced Acute Interstitial Nephritis

    Dennis G. Moledina;Mark A. Perazella

Frequent Co-Authors

Steven G. Coca
Steven G. Coca Icahn School of Medicine at Mount Sinai
Chirag R. Parikh
Chirag R. Parikh Johns Hopkins University
Camillo Porta
Camillo Porta University of Bari Aldo Moro
Claudio Ronco
Claudio Ronco University of Padua
Glen S. Markowitz
Glen S. Markowitz Columbia University
David C. Wheeler
David C. Wheeler University College London
Jeffrey C. Weinreb
Jeffrey C. Weinreb Yale University
Sharon M. Moe
Sharon M. Moe Indiana University
Guadalupe Garcia-Tsao
Guadalupe Garcia-Tsao Yale University
Kanwaljit Chopra
Kanwaljit Chopra Panjab University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If medical school isn’t your only interest, a variety of online degrees and healthcare career pathways are available in the USA. Many students consider direct admit nursing programs for efficient entry into the nursing field, allowing them to start their nursing education without waiting for competitive admissions after prerequisites.

Those seeking office-based healthcare careers might look into accredited medical billing and coding schools with financial aid. These programs often offer flexible schedules and financial support, making it easier to transition into administrative roles in healthcare.

For nurses aiming to advance, there are lpn to rn programs without teas test requirements, which remove some traditional testing barriers. This streamlines the process for licensed practical nurses to become registered nurses.

For those interested in leadership or administrative roles, an online healthcare management degree offers a fast path to careers in healthcare business and management. These programs are ideal for students seeking flexible, accredited options for upward mobility within the healthcare system.

Best Scientists Citing Mark A. Perazella

Trending Scientists

Recently Published Articles